Practical guide to vaccination in all stages of CKD, including patients treated by dialysis or kidney transplantation

KM Krueger, MG Ison, C Ghossein - American Journal of Kidney Diseases, 2020 - Elsevier
Infection is a major cause of morbidity and mortality in patients with chronic kidney disease
(CKD), including those receiving maintenance dialysis or with a kidney transplant. Although …

Pneumococcal vaccination in adult solid organ transplant recipients: A review of current evidence

C Dendle, RL Stuart, WR Mulley, SR Holdsworth - Vaccine, 2018 - Elsevier
This narrative review summarizes the current literature relating to pneumococcal vaccination
in adult solid organ transplant (SOT) recipients, who are at risk of invasive pneumococcal …

The association of pneumococcal vaccination with hospitalization and mortality in hemodialysis patients

DT Gilbertson, H Guo, TJ Arneson… - Nephrology Dialysis …, 2011 - academic.oup.com
Background. Few studies have examined the effectiveness of pneumococcal vaccination
(alone or with influenza vaccination) in improving hemodialysis patient outcomes. We aimed …

The ABC of pneumococcal infections and vaccination in patients with chronic kidney disease

SJ Vandecasteele, S Ombelet, S Blumental… - Clinical kidney …, 2015 - academic.oup.com
Background In the general population, pneumococcal polysaccharide vaccines (PPV)
decrease the incidence of invasive pneumococcal disease (IPD) whereas the impact on the …

Utilizing the health belief model to assess vaccine acceptance of patients on hemodialysis.

A Adams, M Hall, J Fulghum - Nephrology Nursing Journal, 2014 - search.ebscohost.com
Vaccine rates in patients on hemodialysis are substantially lower than the Healthy People
2020 targets. The purpose of this study is to utilize the perceptions and cues for action …

Immunogenicity of 13-valent conjugate pneumococcal vaccine in patients 50 years and older with end-stage renal disease and on dialysis

S Mitra, GE Stein, S Bhupalam… - Clinical and Vaccine …, 2016 - Am Soc Microbiol
Patients with end-stage renal disease (ESRD) and on dialysis are at increased risk of
pneumococcal disease. We evaluated the immunogenicity of the 13-valent pneumococcal …

Immunization in end‐stage renal disease: opportunity to improve outcomes

R Soni, B Horowitz, M Unruh - Seminars in dialysis, 2013 - Wiley Online Library
Infection is the second most common cause of death in patients with end‐stage renal
disease (ESRD), following cardiovascular causes. Immunization is a fairly simple, but …

[HTML][HTML] Immunogenicity and safety of double dosage of pneumococcal vaccines in adult kidney transplant recipients and waiting list patients: A non-blinded …

L Larsen, C Bistrup, SS Sørensen, L Boesby… - Vaccine, 2022 - Elsevier
Background Pneumococcal prime-boost vaccination is recommended for solid organ
transplant recipients, but is not thoroughly tested in this population. Furthermore, a …

[HTML][HTML] Immunogenicity and safety of the 13-valent Pneumococcal Conjugate vaccine in 23-valent pneumococcal polysaccharide vaccine-naive and pre-immunized …

SJ Vandecasteele, D De Bacquer, R Caluwe… - Clinical Microbiology …, 2018 - Elsevier
Objective To benchmark the immunogenicity of pneumococcal conjugated vaccine (PCV-13)
versus pneumococcal polysaccharide vaccine (PPV-23) in haemodialysis patients pre …

Antibody response to pneumococcal capsular polysaccharide vaccination in patients with chronic kidney disease

M Mahmoodi, A Aghamohammadi… - European Cytokine …, 2009 - eprints.bmsu.ac.ir
Patients with chronic kidney disease (CKD) or on dialysis are at greater risk of infection,
which might be due to a defective immune function. While there are controversial reports on …